Tag: Meningioma

More than 1,200 Depo-Provera lawsuits were pending in a federal multidistrict litigation as of October 2025. These legal actions center on **what is the lawsuit against Depo-Provera meningioma?**, alleging the birth control shot's manufacturer failed to warn users about the risk of developing brain tumors.

Scientific evidence suggests prolonged use of the injectable contraceptive Depo-Provera can increase the risk of developing a brain tumor known as a meningioma. Understanding **who qualifies for the Depo-Provera lawsuit** is the first step for those seeking recourse for these serious health complications.

Depo-Provera, the injectable contraceptive, has not been officially discontinued or recalled by the U.S. Food and Drug Administration (FDA). Despite rumors suggesting otherwise, the product remains available by prescription, though it is at the center of growing lawsuits and regulatory warnings that explain why people ask, 'Why was Depo-Provera discontinued?'.

Despite ongoing legal challenges and a history of safety concerns, the injectable contraceptive Depo-Provera is not banned in the USA and remains available by prescription. The persistent question, 'Is Depo banned in the USA?', stems from a controversial past that includes multiple FDA reviews and recent findings linking long-term use to serious health risks.

Studies have shown that certain types of hormonal exposure are linked to an increased risk of meningioma, a generally benign brain tumor that is more common in women. This has led many to question: **Can birth control pills cause meningioma?** The answer is nuanced, depending heavily on the specific hormonal compounds used.

While meningiomas are often benign and their exact cause remains unclear, recent large-scale studies have identified a significant association between the long-term use of certain progestogen medications and an increased risk of developing this type of brain tumor. This finding highlights a crucial area of pharmacovigilance for hormone-based therapies.

According to a March 2024 study published in *The British Medical Journal*, long-term use of the injectable contraceptive Depo-Provera (medroxyprogesterone acetate) was associated with a significantly increased risk of developing a meningioma, a type of brain tumor. These findings have prompted legal and medical scrutiny, raising important questions for millions of women regarding whether Depo-Provera causes meningioma.

Recent large-scale studies in France and the US have found that prolonged, high-dose use of specific progestogen-based medications significantly increases the risk of developing intracranial meningiomas, a type of brain tumor. The question, **what drugs cause meningiomas**, is increasingly being addressed with evidence pointing toward hormonal agents.